Anastomotic Outcomes in Idiopathic Pulmonary Fibrosis Patients Receiving Anti-Fibrotic Therapy: Experience of the Australian Lung Transplant Collaborative

被引：0
|
作者：
Mackintosh, J. [1 ]
Munsif, M. [2 ]
Thomson, C. [3 ]
Musk, M. [4 ]
Snell, G. [2 ]
Glanville, A. [3 ]
Chambers, D. [1 ]
Hopkins, P. [1 ]
机构：
[1] Prince Charles Hosp, Lung Transplant Unit, Brisbane, Qld, Australia
[2] The Alfred, Lung Transplant Serv, Melbourne, Vic, Australia
[3] St Vincents Hosp, Lung Transplant Unit, Sydney, NSW, Australia
[4] Royal Perth Hosp, Lung Transplant Unit, Perth, WA, Australia
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2018年 / 37卷 / 04期
关键词：
D O I：
10.1016/j.healun.2018.01.208
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
205
引用
收藏
页码：S89 / S90
页数：2
相关论文
共 50 条
  • [1] Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis
    Astor, Todd L. L.
    Goldberg, Hilary J. J.
    Snyder, Laurie D. D.
    Courtwright, Andrew
    Hachem, Ramsey
    Pena, Tahuanty
    Zaffiri, Lorenzo
    Criner, Gerard J. J.
    Budev, Marie M. M.
    Thaniyavarn, Tany
    Leonard, Thomas B. B.
    Bender, Shaun
    Barakat, Aliaa
    Breeze, Janis L. L.
    LaCamera, Peter
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2023, 17
  • [2] Anti-Fibrotic Therapy and Patient Reported Outcomes in Idiopathic Pulmonary Fibrosis
    Kay, S.
    White, E. S.
    Sheth, J. S.
    Flaherty, C.
    Getty, C.
    Holtze, C.
    Wang, B.
    Salisbury, M.
    Belloli, E.
    Flaherty, K. R.
    Murray, S.
    Xia, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [3] Risk of anastomotic dehiscence in patients with pulmonary fibrosis transplanted while receiving anti-fibrotics: Experience of the Australian Lung Transplant Collaborative
    Mackintosh, John A.
    Munsif, Maitri
    Ranzenbacher, Lucy
    Thomson, Claire
    Musk, Michael
    Snell, Gregory
    Glanville, Allan
    Chambers, Daniel C.
    Hopkins, Peter
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (05): : 553 - 559
  • [4] Outcome of lung transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy
    Leuschner, Gabriela
    Stocker, Florian
    Veit, Tobias
    Kneidinger, Nikolaus
    Winter, Hauke
    Schramm, Rene
    Weig, Thomas
    Matthes, Sandhya
    Ceelen, Felix
    Arnold, Paola
    Munker, Dieter
    Klenner, Friederike
    Hatz, Rudolf
    Frankenberger, Marion
    Behr, Juergen
    Neurohr, Claus
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (02): : 268 - 274
  • [5] Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis
    Yoshikawa, Takumi
    Otsuka, Mitsuo
    Chiba, Hirofumi
    Ikeda, Kimiyuki
    Mori, Yuki
    Umeda, Yasuaki
    Nishikiori, Hirotaka
    Kuronuma, Koji
    Takahashi, Hiroki
    BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [6] Correction to: Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis
    Takumi Yoshikawa
    Mitsuo Otsuka
    Hirofumi Chiba
    Kimiyuki Ikeda
    Yuki Mori
    Yasuaki Umeda
    Hirotaka Nishikiori
    Koji Kuronuma
    Hiroki Takahashi
    BMC Pulmonary Medicine, 20
  • [7] Characteristics Of Patients With Idiopathic Pulmonary Fibrosis (ipf) Receiving Approved Anti-Fibrotic Therapies In The Us
    Gamerman, V.
    Salisbury, M.
    Culver, D.
    Leonard, T.
    Neely, M. L.
    Yow, E.
    Conoscenti, C. S.
    Palmer, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [8] Factors Affecting The Selection Of Anti-Fibrotic Therapy For Idiopathic Pulmonary Fibrosis
    Kaur, R.
    King, C.
    Brown, A.
    Ahmad, S.
    Shlobin, O. A.
    Weir, N.
    Nathan, S. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [9] A HUMAN MODEL OF LUNG FIBROSIS FOR THE ASSESSMENT OF ANTI-FIBROTIC STRATEGIES IN IDIOPATHIC PULMONARY FIBROSIS
    Roach, K. M.
    Tongue, P.
    Castells, E.
    Elliot, G.
    Marshall, H.
    Richardson, M.
    Mason, S.
    Chachi, L.
    Bradding, P.
    THORAX, 2019, 74 : A56 - A57
  • [10] Anti-fibrotic effects of pirfenidone in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Hostettler, Katrin
    Papakonstantinou, Eleni
    Klagas, Ioannis
    Bonovolias, Ioannis
    Sun, Qingzhu
    Tamm, Michael
    Lambers, Christopher
    Roth, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
12345